Mersana Therapeutics Statistics

Total Valuation

MRSN has a market cap or net worth of $264.98 million. The enterprise value is $138.85 million.

Market Cap	264.98M
Enterprise Value	138.85M

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024, before market open.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

MRSN has 122.68 million shares outstanding. The number of shares has increased by 14.96% in one year.

Shares Outstanding	122.68M
Shares Change (YoY)	+14.96%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	1.32%
Owned by Institutions (%)	54.53%
Float	72.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.87
Forward PS	n/a
PB Ratio	31.88
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 3.91.

Current Ratio	2.72
Quick Ratio	2.64
Debt / Equity	3.91
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25.46

Financial Efficiency

Return on equity (ROE) is -213.33% and return on invested capital (ROIC) is -77.52%.

Return on Equity (ROE)	-213.33%
Return on Assets (ROA)	-26.30%
Return on Capital (ROIC)	-77.52%
Revenue Per Employee	$243,390
Profits Per Employee	-$851,821
Employee Count	123
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +70.08% in the last 52 weeks. The beta is 1.47, so MRSN's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	+70.08%
50-Day Moving Average	1.73
200-Day Moving Average	2.82
Relative Strength Index (RSI)	66.64
Average Volume (20 Days)	1,133,068

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MRSN had revenue of $29.94 million and -$104.77 million in losses. Loss per share was -$0.86.

Revenue	29.94M
Gross Profit	-58.02M
Operating Income	-103.11M
Pretax Income	-134.81M
Net Income	-104.77M
EBITDA	-101.41M
EBIT	-103.11M
Loss Per Share	-$0.86

Full Income Statement

Balance Sheet

The company has $162.74 million in cash and $32.93 million in debt, giving a net cash position of $129.81 million or $1.06 per share.

Cash & Cash Equivalents	162.74M
Total Debt	32.93M
Net Cash	129.81M
Net Cash Per Share	$1.06
Equity (Book Value)	8.43M
Book Value Per Share	0.07
Working Capital	106.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$132.56 million and capital expenditures -$990,000, giving a free cash flow of -$133.55 million.

Operating Cash Flow	-132.56M
Capital Expenditures	-990,000
Free Cash Flow	-133.55M
FCF Per Share	-$1.09

Full Cash Flow Statement

Margins

Gross Margin	-193.81%
Operating Margin	-344.43%
Pretax Margin	-349.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-454.13%

Dividends & Yields

MRSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.96%
Shareholder Yield	-14.96%
Earnings Yield	-39.00%
FCF Yield	-49.71%

Analyst Forecast

The average price target for MRSN is $6.00, which is 177.78% higher than the current price. The consensus rating is "Buy".

Price Target	$6.00
Price Target Difference	177.78%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	50.40%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MRSN has an Altman Z-Score of -6.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.72
Piotroski F-Score	2